Search Within

Kevin Joseph Curran

  1. "Hematologic Malignancies Research"
Formats
  1. Meeting Abstract (35)
  2. Journal Article (21)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (57)
  2. Department of Medicine (57)
  3. GSK Faculty (57)
  4. Hematologic Malignancies Research (57)
  5. Pediatrics, Department of (57)
  6. Stem Cell Transplantation and Cellular Therapy Service (57)

More Groups

People
  1. Renier Brentjens (47)
  2. Isabelle Riviere (39)
  3. Michel Sadelain (36)
  4. Jae Park (32)
  5. Xiuyan Wang (30)
  6. Craig Sauter (24)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (5)
  5. 2020 (4)
  6. 2019 (6)

More Years

Publications
  1. Blood (19)
  2. Biology of Blood and Marrow Transplantation (4)
  3. Bone Marrow Transplantation (4)
  4. Journal of Clinical Oncology (4)
  5. Molecular Therapy (4)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (21)
  2. Nature Publishing Group (12)
  3. American Society of Clinical Oncology (4)
  4. Elsevier Inc. (4)
  5. American Association for Cancer Research (2)
  6. American Association for the Advancement of Science (2)

More Publishers

Results (57)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safe and effective re-induction of complete remissions in adults with relapsed B-ALL using 19-28z CAR CD19-targeted T cell therapy
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Taylor, C.; Wasielewska, T.; Qu, J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia
    Journal Article

    Brentjens, R. J.; Davila, M. L.; Riviere, I.; Park, J.; Wang, X.; Cowell, L. G.; Bartido, S.; Stefanski, J.; Taylor, C.; Olszewska, M.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen
    Journal Article

    Brentjens, R. J.; Curran, K. J.
    Hematology-American Society of Hematology Education Program (2012)

    Fulltext@MSK | Save
  • Constitutive expression of CD40L by CAR-modified tumor targeted T cells enhances anti-tumor efficacy both in vitro and in vivo
    Meeting Abstract

    Curran, K. J.; Seinstra, B.; Nikhamin, Y.; Yeh, R.; Usachenko, Y.; Brentjens, R. J.
    Blood (2012)

    Fulltext@MSK | Save
  • CD19 targeted allogeneic EBV-specific T cells for the treatment of relapsed ALL in pediatric patients post HSCT
    Meeting Abstract

    Curran, K. J.; Kernan, N. A.; Wang, X. Y.; Taylor, C.; Doubrovina, E.; Bartido, S.; Sadelain, M.; O'Reilly, R. J.; Brentjens, R. J.; Riviere, I.
    Blood (2012)

    Fulltext@MSK | Save
  • Chimeric antigen receptors for T cell immunotherapy: Current understanding and future directions
    Journal Article

    Curran, K. J.; Pegram, H. J.; Brentjens, R. J.
    Journal of Gene Medicine (2012)

    Fulltext@MSK | Save
  • Virus specific T-lymphocytes genetically modified to target the CD19 antigen eradicates systemic lymphoma in mice
    Meeting Abstract

    Curran, K. J.; Taylor, C.; Doubrovina, E.; Wang, X.; O'Reilly, R. J.; Sadelain, M.; Kernan, N. A.; Brentjens, R. J.; Riviere, I.
    Blood (2010)

    Fulltext@MSK | Save